Clorox (NYSE: CLX) reported Q3 EPS of $1.08, $0.02 worse than the analyst estimate of $1.10. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.38 billion.

Clorox sees FY2015 EPS of $4.45-$4.55, versus prior guidance of $4.40-$4.55 and the consensus of $4.52. It sees:

• 1% to 2% sales growth (previously about 1% sales growth)
• EBIT margin about flat (unchanged)

For earnings history and earnings-related data on Clorox (CLX) click here.